← back to search

Wei Qin

Nanjing University of Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Cholangiocarcinoma and Gallbladder Cancer Studies, and Circular RNAs in diseases.
h-index
29
citations
4,109
works
127
NIH funding
primary concept
email

Recent publications

Long non-coding RNA NAV2-AS2 protects against atherosclerosis by regulating EndMT through sense-antisense hybrid formation with NAV2 mRNA
International Journal of Biological Macromolecules 2025cited by 1position: lastdoi
Design and optimization of the seed feeding device with DEM-CFD coupling approach for rice and wheat
Computers and Electronics in Agriculture 2024cited by 34position: middledoi
Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure
International Journal of Oral Science 2024cited by 20position: middledoi
Integrin A5B1-mediated endocytosis of polystyrene nanoplastics: Implications for human lung disease and therapeutic targets
The Science of The Total Environment 2024cited by 20position: middledoi
Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer
Nature Communications 2021cited by 174position: middledoi
Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment
Biomaterials Science 2020cited by 113position: middledoi
Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis
Theranostics 2020cited by 44position: firstdoi
Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway
Cell Death and Disease 2019cited by 49position: middledoi
SIRT6-mediated transcriptional suppression of MALAT1 is a key mechanism for endothelial to mesenchymal transition
International Journal of Cardiology 2019cited by 27position: firstdoi
Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma
Pathology - Research and Practice 2019cited by 25position: middledoi
Metoprolol protects against myocardial infarction by inhibiting miR-1 expression in rats
Journal of Pharmacy and Pharmacology 2019cited by 16position: firstdoi
SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma
Journal of Experimental & Clinical Cancer Research 2018cited by 177position: middledoi
Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells
Biochemical and Biophysical Research Communications 2018cited by 171position: middledoi
Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma
Scientific Reports 2018cited by 62position: firstdoi
Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition
Biomedicine & Pharmacotherapy 2018cited by 29position: middledoi
miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma
Cellular Physiology and Biochemistry 2018cited by 20position: middledoi
Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma
Oncotarget 2017cited by 44position: middledoi
Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway
Toxicology Letters 2016cited by 63position: middledoi
MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis
Scientific Reports 2015cited by 153position: middledoi
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
Cell Death and Disease 2014cited by 316position: middledoi
β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression
Journal of Molecular and Cellular Cardiology 2014cited by 113position: middledoi
Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
Journal of Ethnopharmacology 2014cited by 85position: middledoi
Genistein alleviates pressure overload‐induced cardiac dysfunction and interstitial fibrosis in mice
British Journal of Pharmacology 2014cited by 69position: firstdoi
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells
International Journal of Oncology 2014cited by 33position: firstdoi
<scp>S</scp>ox2 targets cyclin<scp>E</scp>, p27 and survivin to regulate androgen‐independent human prostate cancer cell proliferation and apoptosis
Cell Proliferation 2012cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiangyu Zhong · Tohoku University8 papers (2017–2019)Yi Xu · Central South University8 papers (2017–2019)Yong Zhang · Inner Mongolia Agricultural University7 papers (2014–2020)Kaiming Leng · Qingdao University7 papers (2017–2019)Chaoqian Xu · Ministry of Education of the People's Republic of China6 papers (2014–2019)Pengcheng Kang · Harbin Medical University6 papers (2017–2019)Longyin Zhang · Harbin Medical University6 papers (2014–2020)Yunfu Cui · Harbin Medical University6 papers (2017–2018)Zhenglong Li · Harbin Medical University5 papers (2017–2019)Xingming Jiang · Harbin Medical University5 papers (2017–2019)Ning Du · Northeastern University5 papers (2014–2015)Zhange Li · Harbin Medical University5 papers (2015–2020)Xiaoguang Li · Qilu Hospital of Shandong University4 papers (2014–2015)Dan Xiao · Nanchang University4 papers (2015–2020)Nannan Shen · Harbin Medical University4 papers (2014–2015)Zhiwei Fang · Johns Hopkins University4 papers (2014–2016)Yue Yao · Nanjing Drum Tower Hospital4 papers (2017–2018)Lining Huang · Harbin Medical University4 papers (2018–2019)Baofeng Yang · Shenyang Pharmaceutical University3 papers (2014–2019)Zhidong Wang · Harbin Medical University3 papers (2018–2019)